Sumitomo Life Insurance First In Japan To Cover All Cancer Treatments
This article was originally published in PharmAsia News
Sumitomo Life Insurance announced a special cancer security contract that promises to cover all pharmaceuticals used in cancer treatment, including new drugs that do not yet exist, provided that public health insurance applies to the cases in question.
You may also be interested in...
In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.
A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.